Determination of Diabetes and Dyslipidemia Goals in the Management of Diabetes

Diabetes Type I and Type II have an increased risk of early atherosclerotic CVD, such as CHD and PAD [1], and it is well known that glucose control improves TG levels and cholesterol-lowering has beneficial effects on CVD outcomes in T1DM and T2DM.

Author (S) Details

Rajesh Jain
Diabetes Prevention Control Project, National Health Mission, India.

Susanne Olejas
World Diabetes Foundation, Denmark.

Sanjeev Davey
Muzaffarnagar Medical College, India.

Rachna Jain
Department of Obstetrics & Gynecology, Jain Hospital, India.

Reza Shoghli
Department of Cardiology, Azad University of Tehran, Iran.

Mohammad Iqbal
Consultant Diabetes in Dubai and UK.

Seyed Hoseyn Ahmadi Tafti
Tehran Heart Centre, Tehran, Iran.

Siyamak Jalal hosseini
Tehran Heart Centre, Tehran, Iran.

View Book :-

Leave a Reply

Your email address will not be published.

Previous post Economical and Evidence Based “A Single Test Procedure” for Diagnosing GDM is Likely to be Globally Relevant
Next post Techniques of Writing Chapter 1 for Research and Development in Public Health